Page 1

EXHIBIT 99.1 Zomedica Announces Record Second Quarter Revenue of $ 9.5 Million , Up 37 % Year - Over- Year , Net Loss Reduced 49 % , with $ 44.1 Million in Liquidity Zomedica surpasses $ 9 million in second quarter revenue for the first time while extending its record of consecutive year - over - year revenue growth to 22 quarters . ANN ARBOR , MI / ACCESSWIRE / August 5 , 2026 / Zomedica Corp. ( OTCQB : ZOMDF ) ( " Zomedica " or the " Company " ) , an animal health company offering innovative point - of - care diagnostic and therapeutic products for equine and companion animals , today reported consolidated financial results for the three and six months ended June 30 , 2026 . " Delivering 37 % growth and achieving record year - over - year revenue for the 22nd consecutive quarter reflects continued execution across the business . " said Larry Heaton , Chief Executive Officer of Zomedica . " Growth in the quarter was driven by continued strength in our Pulse Vet® and AssisiⓇ therapeutic device products , increasing adoption of our diagnostic offerings , particularly our TRUFORMA® platform , and contributions from our newly formed Development Services segment . As a result , we delivered the strongest second quarter in Zomedica's history , surpassing the prior record of $ 7.0 million established in the second quarter of 2025 . “ Commercial initiatives within our Diagnostics segment , including our collaboration with Boehringer Ingelheim Animal Health , assays that provide point - of - care diagnoses for the equine market , and expansion into additional international territories , continue to deliver encouraging results , as evidenced by 77 % growth within the segment . " We also continue to make meaningful progress within our Development Services segment , providing another opportunity to leverage our engineering , development , and manufacturing expertise while generating additional revenue and improving operating leverage over time . " The Development Services business segment has generated revenue of $ 3.4 million through the second quarter of 2026 , and $ 6.4 million since its introduction in the second half of 2025 , demonstrating our ability to create new revenue streams by leveraging capabilities that already exist across our organization .